ELR+ CXC chemokines such as CXCL1 and CXCL8, as well as their CXCR1/CXCR2 receptors, have been demonstrated to be significant factors in promoting CSC enrichment in breast cancer. The gene discussed is CXCR2; the disease is breast carcinoma.